Bertha Coombs

As broader approval for GLP-1 weight loss drugs spurs higher demand, it's also causing employer drug spending to spike.

In clinical trials, the accuracy of self-testing with Teal's wand matched that of a cancer screening performed in a doctor's office.

Kara Egan founded Teal Health during the pandemic, looking to make it easier for women to get preventive cervical cancer screening more easily. Five years later, the FDA has approved the startup’s self-administered HPV testing wand, which in clinical trials proved to be just as accurate as the swabs done in a doctor’s office. Egan spoke with Bertha Coombs about why she sees this is a gamechanger for women.

Cigna's pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Investors will be looking for a path to a turnaround from UnitedHealth's earnings release, after an abrupt CEO change and over 40% drop in the company's stock.

Health care inflation is rising, helping to fuel what is expected to be the biggest rise in employer health spending in 15 years in 2026.

CMS sees Medicare Advantage enrollment falling in 2026, as insurers facing lower profits cut back on unprofitable plans

Eli Lilly and Novo Nordisk shares dropped after President Donald Trump said he wants a $150 price tag for GLP-1s.

Novo Nordisk released new data to underscore its pill's safety and effectiveness, while Trump is asked whether private plans could see lower GLP-1 costs.

Republicans are proposing alternatives to Obamacare enhanced tax credits, with the enrollment deadline just three weeks away.